April 13, 2026

Antivirals Linked to Lower Hospitalization in Influenza

Matched cohort study in nonhospitalized patients

Conexiant

April 13, 2026

AI Falls Short on Differential Dx

New PrIME-LLM benchmark shows strong diagnostic accuracy but persistent gaps in clinical reasoning across 21 large language models

Conexiant

April 10, 2026

Influenza Vaccine Dose and Dementia Outcomes

US claims data compare high- vs standard-dose formulations in patients aged 65 years or more over 3 years of follow-up

Conexiant

April 07, 2026

Flu Vaccination Linked to Lower Heart, Stroke Risk After Infection

A Danish registry study suggests prior influenza vaccination is associated with lower short-term cardiovascular risk following breakthrough infection.

Conexiant

April 06, 2026

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

Conexiant

April 02, 2026

CDC Lists Dozens of Infectious Disease Tests as Unavailable

More than two dozen assays paused or discontinued, with alternative testing options noted

Conexiant

March 30, 2026

Extended Viral PCR: Does It Help?

Researchers evaluate whether extended viral PCR testing is associated with antibiotic use and length of stay in adult inpatients.

Conexiant

March 17, 2026

Flu Vaccine Cut Hospitalizations Despite Drifted H3N2 Strain

Interim CDC estimates found the 2025–2026 vaccine reduced outpatient influenza visits by up to 41% and hospitalizations by up to 41%.

Conexiant

April 24, 2023

Hitting a Moving Target

Flu is a protean creature. How can we pin it down?

The Medicine Maker

June 13, 2018

The Winning Formula

Meet the three frontrunners of The Medicine Maker 2017 Innovation Awards – spanning influenza vaccine development, a virtual reality space, and a way to boost monoclonal antibody manufacturing. Is there a recipe for success?

The Medicine Maker